卓悦(00653.HK)曾飙逾1倍至0.385元创近三年高 或与香港华为展开联合品牌营销
卓悦控股(00653.HK)与香港华为就可能合作展开联合品牌营销订立谅解备忘录,该股扭转逾两个月横行兼升破52周高位0.28元,曾飙1.1倍至0.385元,为2018年6月以来最高,现造0.31元,飙69%,一向疏落成交激增至4.75亿股,涉资1.51亿元。
卓悦公布,全资附属公司卓悦科技服务与香港华为国际就应用新零售科技服务创新以支持集团业务转型和可持续发展以及启动双方在联合品牌营销方面合作订立不具约束力谅解备忘录。鉴於可能进行之合作事项,董事认为,如果实现,将使集团能够进一步优化电子商务零售及相关发展,提高其盈利能力,为股东带来更可观回报。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.